Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

2015819 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 386, Issue 9993, pp. 541-551

Field-Weighted Citation Impact: 48.62